Ophthalmic Case Studies and Novel Approach


In a small randomized controlled trial, production of aqueous tears and secretion of goblet cells increased following application of the Oculeve Intranasal Lacrimal Neurostimulator (Allergan).1 This handheld device works by delivering electrical stimulation to the anterior ethmoidal branch of the trigeminal nerve in the nasal cavities. It potentially offers a new mechanism for treating dry eye disease—now largely managed with artificial tears and anti-inflammatory agents.


    Related Conference of Ophthalmic Case Studies and Novel Approach

    August 28-29, 2024

    5th International Conference on Euro Ophthalmology and Eye Surgery

    Aix-en-Provence, France
    September 12-13, 2024

    5th International Conference on Optometry

    Paris, France
    October 10-11, 2024

    34th World Congress on Ophthalmology and Optometry

    Madrid, Spain
    October 10-11, 2024

    10th Global Ophthalmology Meeting

    Madrid, Spain
    October 17-18, 2024

    24th Global Ophthalmologists Annual Meeting

    London, UK
    March 17-18, 2025

    39th European Ophthalmology Congress

    Berlin, Germany
    April 29-30, 2025

    35th International Congress on Vision Science and Eye

    Barcelona, Spain

    Ophthalmic Case Studies and Novel Approach Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in